Endocrine Testing Market to Reach USD 10.6 Bn CAGR of 6.4% from 2019 to 2027: As per TMR Study

𝐄𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐞 𝐭𝐞𝐬𝐭𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 to reach US$ 10.6 Bn by 2027, it is anticipated to expand at a CAGR of 6.4% from 2019 to 2027.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1645&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

The endocrine system comprises glands that release hormones directly into the bloodstream, and tests are conducted to monitor hormone levels such as FSH, LH, estradiol, and insulin from biological samples.

These tests help detect deviations in hormone production, aiding in the diagnosis of endocrine disorders like infertility, menopause, and thyroid dysfunction, caused by hypersecretion or hyposecretion.

Disorders like diabetes and PCOS are contributing to the increased demand for endocrine testing, with rising prevalence highlighted in studies like Current Diabetes Reports.

Sedentary lifestyles and unhealthy diets are driving the surge in diabetes prevalence, with global numbers projected to rise significantly according to Diabetes Research and Clinical Practice.

To meet the growing demand for testing methods with rapid results, key players are investing in research and development, introducing products with new technologies to address market needs and drive growth.

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐩𝐥𝐚𝐲𝐞𝐫𝐬:

Agilent Technologies,,F-Hoffmann La Roche Ltd,AB SCIEX,,Thermo Fisher Scientific,Abbott Laboratories,Bio-Rad Laboratories,DiaSorin S.p.A,Beckman Coulter Inc,Siemens Healthineers and bioMerieux

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐓𝐞𝐬𝐭 𝐓𝐲𝐩𝐞

Estradiol (E2) Test
Follicle Stimulating Hormone (FSH) Test
Human Chorionic Gonadotropin (hCG) Test
Luteinizing Hormone (LH) Test
Dehydroepiandrosterone sulfate (DHEAS) Test
Progesterone Test
Testosterone Test
Thyroid Stimulating Hormone (TSH) Test
Prolactin Test
Cortisol Test
Insulin Test
Others (Gastrin, Thymosin, Secretin, etc.)

𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬

Tandem Mass Spectrometry
Immunoassay technologies
Monoclonal and Polyclonal Antibody Technologies
Sensor Technologies
Clinical Chemistry Technologies

𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Commercial Laboratories
Ambulatory Care Centers
Home Based tests
Physician Offices

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=1645<ype=S&utm_source=OpenPR&utm_medium=OpenPR&utm_campaign=MansiR

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬

In May 2020, Roche acquired Stratos Genomics to further develop DNA based sequencing for diagnostic use

In March 2020, Thermo Fisher Scientific proposed to acquire QIAGEN N.V. as this acquisition would expand its specialty diagnostics portfolio with attractive molecular diagnostics capabilities, including infectious disease testing

In July 2019, Thermo Fisher Scientific announced a 3 year, US$4.5 million collaboration with Ontario Institute for Cancer Research (OICR) and Genome Canada and the to develop targeted next-generation sequencing-based assays and analysis software.

𝐑𝐞𝐠𝐢𝐨𝐧𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Emergence of innovative endocrine testing solutions, such as point-of-care testing devices, molecular diagnostics, and biomarker-based assays, are among the key trends shaping the market landscape. Moreover, the integration of artificial intelligence and machine learning algorithms in endocrine testing is expected to revolutionize disease diagnosis and treatment.

𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐮𝐭𝐥𝐨𝐨𝐤:

The future of the endocrine testing market looks promising, driven by ongoing research and development activities, strategic collaborations among key players, and growing emphasis on preventive healthcare. Continued advancements in technology and increasing healthcare expenditure are expected to further fuel market growth.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Market Size and Growth Projection
Market Segmentation Analysis
Regional Analysis
Market Drivers and Challenges
Market Trends and Future Outlook
Competitive Landscape and Recent Developments

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐀𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐒𝐭𝐞𝐞𝐥 𝐖𝐡𝐞𝐞𝐥 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/12/2668126/0/en/Automotive-Steel-Wheel-Market-is-Set-to-Reach-US-16-8-Bn-by-year-2031-end-and-Expected-to-Grow-at-a-Whopping-CAGR-of-1-6-Transparency-Market-Research.html

𝐁𝐢𝐨-𝐛𝐚𝐬𝐞𝐝 𝐋𝐞𝐚𝐭𝐡𝐞𝐫 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/05/12/2668097/0/en/Bio-based-Leather-Market-to-Reach-US-1-2-Bn-by-2031-Owing-to-the-rise-in-consumer-demand-fashion-trends-and-technical-properties-of-bio-based-leather-materials.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com        
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.